Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Citigroup Maintains Buy on Amylyx Pharma, Raises Price Target to $37

Citigroup Maintains Buy on Amylyx Pharma, Raises Price Target to $37

Citigroup analyst Neena Bitritto-Garg maintains Amylyx Pharma (NASDAQ:AMLX) with a Buy and raises the price target from $33 to $37.

byBenzinga Newsdesk

July 6, 2022

1 minute read

Citigroup analyst Neena Bitritto-Garg maintains Amylyx Pharma (NASDAQ:AMLX) with a Buy and raises the price target from $33 to $37.

$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today

By Benzinga Insights

October 18, 5:30 PM

Martin Marietta Materials (NYSE:MLM) has outperformed the market over the past 5 years by 10.9% on an annualized…

MLM

What Does Bunge’s Debt Look Like?

By Benzinga Insights

January 27, 1:27 PM

Over the past three months, shares of Bunge Inc. (NYSE:BG) moved lower by 1.04%. Before having a look at the importance of debt, let's look at how much debt Bunge has.

Tesla’s Dominance To Continue In 2024, But Traditional Automakers’ Move To Slow Down EV Game ‘Will Come Back To Haunt Them:’ Munster

By Shanthi Rexaline

January 11, 3:06 AM

Gene Munster said data from Cox, indicating Tesla's 51% market share in the December quarter, solidifies his prediction for the company's continued success.

Toyota Goes All In On Hydrogen As California R&D Office Transforms Into H2HQ

By Anan Ashraf

May 2, 7:58 AM

Toyota's move to establish the H2HQ in California aligns with its attempts at bringing all hydrogen-related work under one roof in other geographies.

Citigroup Maintains Buy on Amylyx Pharma, Raises Price Target to $37

Related Posts

$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today

What Does Bunge’s Debt Look Like?

Tesla’s Dominance To Continue In 2024, But Traditional Automakers’ Move To Slow Down EV Game ‘Will Come Back To Haunt Them:’ Munster

Toyota Goes All In On Hydrogen As California R&D Office Transforms Into H2HQ